395 related articles for article (PubMed ID: 25728464)
21. A case of chromoblastomycosis by Fonsecaea nubica indicating a possible insect route of transmission.
Chen Y; Yin S; Li M; Chen R; Wei L; Ma H; Deng S; de Hoog GS; Lai W; Lu C; Feng P
Mycoses; 2016 Oct; 59(10):662-7. PubMed ID: 27330038
[TBL] [Abstract][Full Text] [Related]
22. A case of cerebral phaeohyphomycosis caused by Fonsecaea monophora, a neurotropic dematiaceous fungus, and a review of the literature.
Doymaz MZ; Seyithanoglu MF; Hakyemez İ; Gultepe BS; Cevik S; Aslan T
Mycoses; 2015 Mar; 58(3):187-92. PubMed ID: 25591071
[TBL] [Abstract][Full Text] [Related]
23. Successful treatment for chromoblastomycosis caused by Fonsecaea monophora: a report of three cases in Guangdong, China.
Zhang J; Xi L; Lu C; Li X; Xie T; Zhang H; Xie Z; De Hoog S
Mycoses; 2009 Mar; 52(2):176-81. PubMed ID: 18627476
[TBL] [Abstract][Full Text] [Related]
24. Photodynamic therapy combined with terbinafine against chromoblastomycosis and the effect of PDT on Fonsecaea monophora in vitro.
Hu Y; Huang X; Lu S; Hamblin MR; Mylonakis E; Zhang J; Xi L
Mycopathologia; 2015 Feb; 179(1-2):103-9. PubMed ID: 25366276
[TBL] [Abstract][Full Text] [Related]
25. A refractory case of chromoblastomycosis due to Fonsecaea monophora with improvement by photodynamic therapy.
Yang Y; Hu Y; Zhang J; Li X; Lu C; Liang Y; Xi L
Med Mycol; 2012 Aug; 50(6):649-53. PubMed ID: 22309458
[TBL] [Abstract][Full Text] [Related]
26. A Case of Chromoblastomycosis Caused by Fonsecaea Pedrosoi and Investigation of the Pathogenic Fungi.
Zhang R; Ran Y; Zhang H; Dai Y; Ran X; Zhang C; Qin W; Xi L
Mycopathologia; 2019 Apr; 184(2):349-352. PubMed ID: 30701405
[No Abstract] [Full Text] [Related]
27. Alternate week and combination itraconazole and terbinafine therapy for chromoblastomycosis caused by Fonsecaea pedrosoi in Brazil.
Gupta AK; Taborda PR; Sanzovo AD
Med Mycol; 2002 Oct; 40(5):529-34. PubMed ID: 12462534
[TBL] [Abstract][Full Text] [Related]
28. Combination of Amphotericin B and Terbinafine against Melanized Fungi Associated with Chromoblastomycosis.
Deng S; Lei W; de Hoog GS; Yang L; Vitale RG; Rafati H; Seyedmousavi M; Tolooe A; van der Lee H; Liao W; Verweij PE; Seyedmousavi S
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29581111
[TBL] [Abstract][Full Text] [Related]
29. In vitro activity of antifungal drugs against Cladophialophora species associated with human chromoblastomycosis.
Vitale RG; Perez-Blanco M; De Hoog GS
Med Mycol; 2009 Feb; 47(1):35-40. PubMed ID: 19115138
[TBL] [Abstract][Full Text] [Related]
30. A case of chromoblastomycosis caused by Fonsecaea pedrosoi in a patient with rheumatoid arthritis.
Ohashi T; Ohtsuka M; Kikuchi N; Nishiyama K; Suzutani T; Yamamoto T
Int J Rheum Dis; 2015 Jun; 18(5):580-1. PubMed ID: 25293579
[No Abstract] [Full Text] [Related]
31. Case Report: A Case of Chromoblastomycosis Caused by Fonsecaea pedrosoi in Vietnam.
Le TA; Nguyen KL; Pham MH; Vi TT; Do NA
Mycopathologia; 2019 Feb; 184(1):115-119. PubMed ID: 29974323
[TBL] [Abstract][Full Text] [Related]
32. Successful treatment of chromoblastomycosis of 36 years duration caused by Fonsecaea monophora.
Najafzadeh MJ; Rezusta A; Cameo MI; Zubiri ML; Yus MC; Badali H; Revillo MJ; De Hoog GS
Med Mycol; 2010 Mar; 48(2):390-3. PubMed ID: 19488919
[TBL] [Abstract][Full Text] [Related]
33. Genetic diversity and species delimitation in the opportunistic genus Fonsecaea.
Najafzadeh MJ; Gueidan C; Badali H; Van Den Ende AH; Xi L; De Hoog GS
Med Mycol; 2009 Feb; 47(1):17-25. PubMed ID: 19107635
[TBL] [Abstract][Full Text] [Related]
34. Itraconazole in the treatment of chromoblastomycosis due to Fonsecaea pedrosoi.
Queiroz-Telles F; Purim KS; Fillus JN; Bordignon GF; Lameira RP; Van Cutsem J; Cauwenbergh G
Int J Dermatol; 1992 Nov; 31(11):805-12. PubMed ID: 1330949
[TBL] [Abstract][Full Text] [Related]
35. Chromoblastomycosis associated with Fonsecaea pedrosoi in a carpenter handling exotic woods.
Menezes N; Varela P; Furtado A; Couceiro A; Calheiros I; Rosado L; Mota G; Baptista A
Dermatol Online J; 2008 Feb; 14(2):9. PubMed ID: 18700112
[TBL] [Abstract][Full Text] [Related]
36. New possibilities for chromoblastomycosis and phaeohyphomycosis treatment: identification of two compounds from the MMV Pathogen Box® that present synergism with itraconazole.
Coelho RA; Alves GM; Figueiredo-Carvalho MHG; Almeida-Silva F; de Souza GR; Lourenço MCDS; Brito-Santos F; Amaral ACF; Almeida-Paes R
Mem Inst Oswaldo Cruz; 2022; 117():e220089. PubMed ID: 36102413
[TBL] [Abstract][Full Text] [Related]
37. Chromoblastomycosis.
Torres-Guerrero E; Isa-Isa R; Isa M; Arenas R
Clin Dermatol; 2012; 30(4):403-8. PubMed ID: 22682188
[TBL] [Abstract][Full Text] [Related]
38. Rapid identification of Fonsecaea by duplex polymerase chain reaction in isolates from patients with chromoblastomycosis.
de Andrade TS; Cury AE; de Castro LG; Hirata MH; Hirata RD
Diagn Microbiol Infect Dis; 2007 Mar; 57(3):267-72. PubMed ID: 17338941
[TBL] [Abstract][Full Text] [Related]
39. Chromoblastomycosis murine model and in vitro test to evaluate the sensitivity of Fonsecaea pedrosoi to ketoconazole, itraconazole and saperconazole.
Cardona-Castro N; Agudelo-Flórez P; Restrepo-Molina R
Mem Inst Oswaldo Cruz; 1996; 91(6):779-84. PubMed ID: 9283666
[TBL] [Abstract][Full Text] [Related]
40. Chromoblastomycosis: a clinical and molecular study of 18 cases in Rio de Janeiro, Brazil.
Mouchalouat Mde F; Gutierrez Galhardo MC; Zancopé-Oliveira RM; Monteiro Fialho PC; de Oliveira Coelho JM; Silva Tavares PM; Francesconi do Valle AC
Int J Dermatol; 2011 Aug; 50(8):981-6. PubMed ID: 21781072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
